Table 1.
Age (Years) | Median | 52.4 | |
---|---|---|---|
Range | 18.4-81.3 | ||
Number of Patients | Percentage | ||
Gender | Male | 39 | 44.8 |
Female | 48 | 55.5 | |
Primary Tumor | Breast | 20 | 23.0 |
Colorectal | 16 | 18.4 | |
Gastroesophageal | 16 | 18.4 | |
Genitourinary | 2 | 2.3 | |
Head and Neck | 7 | 8.0 | |
Leukemia | 5 | 5.7 | |
Lung | 5 | 5.7 | |
Lymphoma | 13 | 14.9 | |
Multiple Myeloma | 2 | 2.3 | |
Thyroid | 1 | 1.1 | |
Khorana Risk Score | Low | 12 | 23.5 |
Intermediate | 26 | 51.0 | |
High | 13 | 25.5 | |
Not applicable | 36 | 41.4 | |
Disease Stage | Advanced | 65 | 74.7 |
Early | 15 | 17.2 | |
Treatment | Chemotherapy | 51 | 58.6 |
Hormonal Therapy | 8 | 9.2 | |
Surgery | 5 | 5.7 | |
Radiation | 2 | 2.3 | |
None | 21 | 24.1 | |
Site of Thrombosisa | Internal Jugular | 38 | 43.7 |
Subclavian | 49 | 56.3 | |
Axillary | 40 | 46.0 | |
Brachial | 21 | 24.1 | |
Central Venous Catheter | Present | 47 | 54.0 |
Absent | 40 | 46.0 |
a More than one vein could be involved; total >87